{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:47:53Z","timestamp":1771998473516,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of the American Dental Association"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.14219\/jada.archive.2013.0134","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T17:36:48Z","timestamp":1390412208000},"page":"406-414","source":"Crossref","is-referenced-by-count":43,"title":["Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction"],"prefix":"10.1016","volume":"144","author":[{"given":"Cesar A.","family":"Migliorati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Kleven","family":"Ingstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Vaagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitzi J.","family":"Palazzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente B.","family":"Herlofson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"36","key":"10.14219\/jada.archive.2013.0134_bib1","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","article-title":"Natural history of osteonecrosis of the jaw in patients with multiple myeloma (published online ahead of print Nov. 17, 2008)","volume":"26","author":"Badros","year":"2008","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.14219\/jada.archive.2013.0134_bib2","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.14219\/jada.archive.2013.0134_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"issue":"5 suppl","key":"10.14219\/jada.archive.2013.0134_bib4","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws: 2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"10.14219\/jada.archive.2013.0134_bib5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"9810","key":"10.14219\/jada.archive.2013.0134_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","article-title":"Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial (published online ahead of print Nov. 15, 2011)","volume":"379","author":"Smith","year":"2012","journal-title":"Lancet"},{"issue":"24","key":"10.14219\/jada.archive.2013.0134_bib7","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab (published online ahead of print Aug. 20, 2008)","volume":"26","author":"Estilo","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.14219\/jada.archive.2013.0134_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/07357900802208608","article-title":"Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents","volume":"27","author":"Aragon-Ching","year":"2009","journal-title":"Cancer Invest"},{"issue":"4","key":"10.14219\/jada.archive.2013.0134_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tripleo.2010.04.049","article-title":"Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases (published online ahead of print Aug. 9, 2010)","volume":"110","author":"Hoefert","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10006-010-0224-y","article-title":"Osteonecrosis of the jaw related to sunitinib (published online ahead of print April 18, 2010)","volume":"15","author":"Koch","year":"2011","journal-title":"Oral Maxillofac Surg"},{"issue":"3","key":"10.14219\/jada.archive.2013.0134_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","article-title":"Sunitinib related osteonecrosis of jaw: a case report (published online ahead of print Jan. 2, 2012)","volume":"113","author":"Fleissig","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer (published online ahead of print April 2, 2010)","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10549-010-0933-9","article-title":"Osteonecrosis of the jaw and bevacizumab therapy (published online ahead of print May 13, 2010)","volume":"122","author":"Van Poznak","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.14219\/jada.archive.2013.0134_bib14","first-page":"1243","article-title":"Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs","volume":"142","author":"Hellstein","year":"2011","journal-title":"JADA"},{"issue":"8","key":"10.14219\/jada.archive.2013.0134_bib15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00520-010-0882-1","volume":"18","author":"Migliorati","year":"2010","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.14219\/jada.archive.2013.0134_bib16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases (published online ahead of print Oct. 10, 2011)","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"issue":"12","key":"10.14219\/jada.archive.2013.0134_bib17","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","article-title":"Osteonecrosis of the jaw: who gets it, and why? (published online ahead of print Oct. 7, 2008)","volume":"44","author":"Reid","year":"2009","journal-title":"Bone"},{"issue":"5","key":"10.14219\/jada.archive.2013.0134_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.joms.2008.01.038","article-title":"Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment","volume":"66","author":"Allen","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"10.14219\/jada.archive.2013.0134_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00198-010-1268-4","article-title":"Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs (published online ahead of print May 11, 2010)","volume":"22","author":"Allen","year":"2011","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.14219\/jada.archive.2013.0134_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.14219\/jada.archive.2013.0134_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? (published online ahead of print May 10, 2007)","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"issue":"5","key":"10.14219\/jada.archive.2013.0134_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? (published online ahead of print July 22, 2009)","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"key":"10.14219\/jada.archive.2013.0134_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","article-title":"Potential pathophysiological mechanisms in osteonecrosis of the jaw (published online ahead of print Feb. 3, 2011)","volume":"1218","author":"Landesberg","year":"2011","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"10.14219\/jada.archive.2013.0134_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-9657.2005.00370.x","article-title":"Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue: a pilot study","volume":"21","author":"Moreira","year":"2005","journal-title":"Dent Traumatol"},{"issue":"11","key":"10.14219\/jada.archive.2013.0134_bib27","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1177\/0022034511420430","article-title":"A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw (published online ahead of print Sept. 15, 2011)","volume":"90","author":"Mawardi","year":"2011","journal-title":"J Dent Res"},{"issue":"10","key":"10.14219\/jada.archive.2013.0134_bib28","first-page":"1259","article-title":"Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"JADA"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11914-010-0008-1","article-title":"The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy","volume":"8","author":"Kumar","year":"2010","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"10.14219\/jada.archive.2013.0134_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00774-009-0128-9","volume":"28","author":"Kobayashi","year":"2010","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"10.14219\/jada.archive.2013.0134_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00198-010-1268-4","article-title":"Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs (published online ahead of print May 11, 2010)","volume":"22","author":"Allen","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.14219\/jada.archive.2013.0134_bib32","series-title":"A Textbook of Oral Pathology","first-page":"601","article-title":"Healing of the extraction wound","year":"1983"},{"issue":"12","key":"10.14219\/jada.archive.2013.0134_bib33","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.joms.2003.08.003","article-title":"Risk factors associated with prolonged recovery and delayed healing after third molar surgery","volume":"61","author":"Phillips","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1359\/jbmr.090713","article-title":"Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs","volume":"25","author":"Allen","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.14219\/jada.archive.2013.0134_bib35","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat (published online ahead of print July 20, 2011)","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.14219\/jada.archive.2013.0134_bib36","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/annonc\/mdl294","article-title":"Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?","volume":"17","author":"Van den Wyngaert","year":"2006","journal-title":"Ann Oncol"},{"issue":"11","key":"10.14219\/jada.archive.2013.0134_bib37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"issue":"11","key":"10.14219\/jada.archive.2013.0134_bib38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","article-title":"Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment","volume":"32","author":"Ficarra","year":"2005","journal-title":"J Clin Periodontol"},{"issue":"3","key":"10.14219\/jada.archive.2013.0134_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.joms.2008.09.031","article-title":"Sinus tracts: an early sign of bisphosphonate-associated osteonecrosis of the jaws?","volume":"67","author":"Mawardi","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"8","key":"10.14219\/jada.archive.2013.0134_bib40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.oraloncology.2012.02.009","article-title":"Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases (published online ahead of print March 7, 2012)","volume":"48","author":"Bagan","year":"2012","journal-title":"Oral Oncol"},{"issue":"7","key":"10.14219\/jada.archive.2013.0134_bib41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1601-0825.2012.01911.x","article-title":"Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines (published online ahead of print March 15, 2012)","volume":"18","author":"Patel","year":"2012","journal-title":"Oral Dis"},{"issue":"6","key":"10.14219\/jada.archive.2013.0134_bib42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1601-0825.2012.01903.x","article-title":"Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ) (published online ahead of print Feb. 22, 2012)","volume":"18","author":"Bedogni","year":"2012","journal-title":"Oral Dis"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10266-010-0153-0","article-title":"The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing (published online ahead of print Jan. 27, 2011)","volume":"99","author":"Allen","year":"2011","journal-title":"Odontology"},{"issue":"6","key":"10.14219\/jada.archive.2013.0134_bib44","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0030-4220(66)90104-6","article-title":"Osseous repair of the postextraction alveolus in man","volume":"21","author":"Boyne","year":"1966","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.joms.2009.07.068","article-title":"Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series","volume":"68","author":"Lodi","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","article-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid (published online ahead of print Aug. 9, 2008)","volume":"20","author":"Dimopoulos","year":"2009","journal-title":"Ann Oncol"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"Ripamonti","year":"2009","journal-title":"Ann Oncol"},{"issue":"2","key":"10.14219\/jada.archive.2013.0134_bib48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.joms.2010.06.200","article-title":"Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw (published online ahead of print Dec. 3, 2010)","volume":"69","author":"Hoefert","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"issue":"12","key":"10.14219\/jada.archive.2013.0134_bib49","first-page":"1658","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper","volume":"136","author":"Migliorati","year":"2005","journal-title":"JADA"},{"issue":"5","key":"10.14219\/jada.archive.2013.0134_bib50","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jbspin.2011.05.003","article-title":"Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis (published online ahead of print July 2, 2011)","volume":"79","author":"Biver","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.14219\/jada.archive.2013.0134_bib52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0501.2010.01965.x","article-title":"Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers? (published online ahead of print Oct. 13, 2010)","volume":"22","author":"Kwon","year":"2011","journal-title":"Clin Oral Implants Res"},{"issue":"6","key":"10.14219\/jada.archive.2013.0134_bib53","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.joms.2009.02.004","article-title":"Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws","volume":"67","author":"Kunchur","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.14219\/jada.archive.2013.0134_bib54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2010.05770.x","article-title":"Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone (published online ahead of print Sept. 29, 2010)","volume":"1218","author":"Cremers","year":"2011","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"10.14219\/jada.archive.2013.0134_bib55","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.4317\/medoral.17583","article-title":"Study of serum CTX in 50 oral surgical patients treated with oral bisphosphonates","volume":"17","author":"Flichy-Fernandez","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"4","key":"10.14219\/jada.archive.2013.0134_bib56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tripleo.2010.04.023","article-title":"Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers (published online ahead of print July 31, 2010)","volume":"110","author":"Fleisher","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.14219\/jada.archive.2013.0134_bib57","author":"Norwegian Institute of Public Health"}],"container-title":["The Journal of the American Dental Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714603901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714603901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T18:54:37Z","timestamp":1565117677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002817714603901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0002817714603901"],"URL":"https:\/\/doi.org\/10.14219\/jada.archive.2013.0134","relation":{},"ISSN":["0002-8177"],"issn-type":[{"value":"0002-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}